Edition:
United States

GB Sciences Inc (GBLX.PK)

GBLX.PK on OTC Markets Group

0.26USD
3:58pm EDT
Change (% chg)

$-0.00 (-0.77%)
Prev Close
$0.26
Open
$0.26
Day's High
$0.26
Day's Low
$0.25
Volume
352,133
Avg. Vol
642,508
52-wk High
$1.56
52-wk Low
$0.21

Chart for

About

GB Sciences, Inc., formerly Growblox Sciences, Inc., is engaged in developing and utilizing technologies in plant biology, cultivation and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. It seeks to be a technology and solution... (more)
No analyst recommendations are available for .

Overall

Beta: -0.87
Market Cap(Mil.): $45.87
Shares Outstanding(Mil.): 181.35
Dividend: --
Yield (%): --

Financials

  GBLX.PK Industry Sector
P/E (TTM): -- 25.26 37.15
EPS (TTM): -0.17 -- --
ROI: -147.04 4.46 59.02
ROE: -218.01 4.94 71.44

BRIEF-GB Sciences Announces The Appointment Of John Davis As Executive VP And General Counsel

* GB SCIENCES ANNOUNCES THE APPOINTMENT OF JOHN B. DAVIS AS EXECUTIVE VP AND GENERAL COUNSEL Source text for Eikon: Further company coverage:

Apr 12 2018

BRIEF-GB Sciences Pursues FDA-Registered, First-In-Human Trial Of Cannabis Based Therapy For Parkinson's Disease

* COMPANY WILL BEGIN ITS TOXICOLOGY STUDIES IN SUMMER OF 2018 Source text for Eikon: Further company coverage:

Apr 10 2018

Earnings vs. Estimates

No consensus analysis data available.